These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27531789)

  • 81. Second unmanipulated allogeneic transplantation could be used as a salvage option for patients with relapsed acute leukemia post-chemotherapy plus modified donor lymphocyte infusion.
    Han T; Sun Y; Liu Y; Yan C; Wang Y; Xu L; Liu K; Huang X; Zhang X
    Front Med; 2021 Oct; 15(5):728-739. PubMed ID: 34279770
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Different Kinetics and Risk Factors for Isolated Extramedullary Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Acute Leukemia.
    Hazar V; Öztürk G; Yalçın K; Uygun V; Aksoylar S; Küpesiz A; Ok Bozkaya İ; Karagün BŞ; Bozkurt C; İleri T; Atay D; Koçak Ü; Karasu GT; Yeşilipek A; Gökçe M; Kansoy S; Kintrup GT; Karakükcü M; Okur FV; Ertem M; Kaya Z; Gürsel O; Yaman Y; Özbek N; Antmen B; Tüfekçi Ö; Albayrak C; Adaklı Aksoy B; Sezgin G; Albayrak D; Evim MS; Zengin E; Pekpak E;
    Transplant Cell Ther; 2021 Oct; 27(10):859.e1-859.e10. PubMed ID: 34216791
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Second allogeneic transplantation for relapsed acute leukemia after initial allogeneic hematopoietic stem cell transplantation.
    Hanajiri R; Ohashi K; Hirashima Y; Kakihana K; Kobayashi T; Yamashita T; Sakamaki H; Akiyama H
    Pathol Oncol Res; 2012 Oct; 18(4):1003-8. PubMed ID: 22544355
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Treatment approach for relapse of adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation].
    Kato K
    Rinsho Ketsueki; 2021; 62(5):505-511. PubMed ID: 34248128
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Isolated Breast Relapse of Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
    Demirsoy ET; Atesoglu EB; Tarkun P; Gedük A; Erdem BE; Hacihanefioglu A; Erçin MC
    Indian J Hematol Blood Transfus; 2016 Jun; 32(Suppl 1):201-4. PubMed ID: 27408391
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Extramedullary relapse of acute myeloid leukemia in brachial plexus after allogeneic stem cell transplantation: a case report.
    Shirota S; Katoh D; Shimomura Y; Imai Y; Ishikawa T
    BMC Neurol; 2022 Jul; 22(1):241. PubMed ID: 35778695
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease.
    Ruben CL; Pirsl F; Steinberg SM; Holtzman NG; Parsons-Wandell L; Baruffaldi J; Curtis LM; Mitchell SA; Kerep AZ; Cowen EW; Berger A; Joe GO; Datiles MB; Mays JW; Pavletic SZ
    Bone Marrow Transplant; 2021 Jul; 56(7):1584-1592. PubMed ID: 33526918
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Treatment of Chronic Graft versus Host Disease -Review].
    Wang FY; Gao CJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):286-290. PubMed ID: 28245418
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Late relapse following allogeneic transplant for chronic lymphocytic leukemia: how good are graft versus leukemia effects?
    Nguyen V; van Besien K
    Leuk Lymphoma; 2008 Sep; 49(9):1651-2. PubMed ID: 18798096
    [No Abstract]   [Full Text] [Related]  

  • 90. Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options-A Single-Center Experience.
    Strassl I; Nikoloudis A; Machherndl-Spandl S; Buxhofer-Ausch V; Binder M; Wipplinger D; Stiefel O; Kaynak E; Milanov R; Aichinger C; Nocker S; Bauer T; Kreissl S; Girschikofsky M; Petzer A; Weltermann A; Clausen J
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136284
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Extramedullary relapse following reduced intensity allogeneic hematopoietic cell transplant for adult acute myelogenous leukemia.
    Kogut N; Tsai NC; Thomas SH; Palmer J; Paris T; Murata-Collins J; Forman SJ
    Leuk Lymphoma; 2013 Mar; 54(3):665-8. PubMed ID: 22906206
    [No Abstract]   [Full Text] [Related]  

  • 92. Frequency, Risk Factors, and Outcome of Active Tuberculosis following Allogeneic Hematopoietic Stem Cell Transplantation.
    Zeng QZ; Zhang YY; Wu YJ; Zhang ZY; Zhang JN; Fu HX; Wang JZ; Wang FR; Yan CH; Mo XD; Wang Y; Chen YH; Chang YJ; Xu LP; Liu KY; Huang XJ; Zhang XH
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1203-1209. PubMed ID: 32105831
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Multivariate Analysis of Immune Reconstitution and Relapse Risk Scoring in Children Receiving Allogeneic Stem Cell Transplantation for Acute Leukemias.
    Spadea M; Saglio F; Tripodi SI; Menconi M; Zecca M; Fagioli F
    Transplant Direct; 2021 Nov; 7(11):e774. PubMed ID: 34646937
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Multiple isolated extramedullary relapse of acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplant: a case report and review of literature.
    Kothari S; Herzig G; Slone S; Herzig R
    Springerplus; 2013 Dec; 2(1):49. PubMed ID: 23476896
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Neurological Complications with Paraplegia as Main Manifestation after Hematopoietic Stem Cell Transplantation].
    Xue S; Zhang YP; Zhang SQ; Xiao TY; Xu YC; Cui B; Wang JB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):595-601. PubMed ID: 32319402
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Risk of relapse in patients receiving azithromycin after allogeneic HSCT.
    Kutzke JL; Merten JA; Taraba JL; Mara KC; Shah MV; Hashmi SK; Patnaik MM; Litzow MR; Hogan WJ; Alkhateeb HB
    Bone Marrow Transplant; 2021 Apr; 56(4):960-962. PubMed ID: 33130820
    [TBL] [Abstract][Full Text] [Related]  

  • 97. What to Look Out for when Transplanting T-Cell Prolymphocytic Leukemia.
    Wahnschaffe L; Herling M
    Acta Haematol; 2021; 144(1):1-3. PubMed ID: 32369824
    [No Abstract]   [Full Text] [Related]  

  • 98. Leukemia relapse after transplantation - a consensus on monitoring, prevention, and treatment in China.
    Zhan H
    BMC Med; 2019 Feb; 17(1):34. PubMed ID: 30744617
    [No Abstract]   [Full Text] [Related]  

  • 99. Analysis of factors associated with hematopoietic stem-cell retransplantation: a case-control study.
    Azevedo IC; Ferreira Júnior MA; Nascimento AAA; Vitor AF; Teston EF; Frota OP; Santos VEP
    Rev Lat Am Enfermagem; 2022; 30():e3569. PubMed ID: 35584411
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The Rochester Relapse Risk Scale: Developing a Standardized Approach to Predicting Substance Relapse in Liver Transplant Candidates.
    Leistman SC; Melaragno JI; Dokus MK; Martens JA; Salter MA; Hutchinson DJ; Hernandez-Alejandro R; Al-Judaibi B; Nickels MW
    Exp Clin Transplant; 2021 Sep; 19(9):919-927. PubMed ID: 34545777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.